Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
Contributions of Fasting and Postprandial Plasma Glucose Increments to the Overall Diurnal Hyperglycemia of Type 2 Diabetic Patients
20031.2k citationsLouis Monnier, H Lapinski et al.Diabetes Careprofile →
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late)
cites ·
hero ref
This map shows the geographic impact of H Lapinski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H Lapinski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H Lapinski more than expected).
This network shows the impact of papers produced by H Lapinski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H Lapinski. The network helps show where H Lapinski may publish in the future.
Co-authorship network of co-authors of H Lapinski
This figure shows the co-authorship network connecting the top 25 collaborators of H Lapinski.
A scholar is included among the top collaborators of H Lapinski based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with H Lapinski. H Lapinski is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Monnier, Louis, H Lapinski, & C Colette. (2003). Contributions of Fasting and Postprandial Plasma Glucose Increments to the Overall Diurnal Hyperglycemia of Type 2 Diabetic Patients. Diabetes Care. 26(3). 881–885.1157 indexed citations breakdown →
Monnier, Louis, A. Avignon, C Colette, & H Lapinski. (1997). Alimentation et athérosclérose : I. Les résultats des études d’interventions nutritionnelles. Sang thrombose vaisseaux. 9(7). 417–427.1 indexed citations
9.
Jaffiol, C, et al.. (1992). [Endemic goiter in the La Kara region (Togo). Analysis of etiologic factors].. PubMed. 176(4). 557–65; discussion 566.2 indexed citations
Seignalet, J, J Cadilhac, & H Lapinski. (1979). [HLA and amyotrophic lateral sclerosis (author's transl)].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 55(23-26). 1239–40.2 indexed citations
15.
Seignalet, J, et al.. (1979). HLA et sclérose latérale amyotrophique.. 55.1 indexed citations
16.
Jaffiol, C, et al.. (1977). [HLA B8 and Graves' disease (author's transl)].. PubMed. 37(4). 219–26.4 indexed citations
Seignalet, J, et al.. (1976). [HL-A antigens in dust allergy in children].. PubMed. 33(10). 955–60.
19.
Guilhou, Jean‐Jacques, Jacques Clot, J Meynadier, & H Lapinski. (1976). Immunological aspects of psoriasis.. British Journal of Dermatology. 94(5). 501–507.68 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.